Search Within

NON-HODGKIN LYMPHOMA
Results 1 - 76 of 76
Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 4
Page: 303-312
Authors: Christine A. White, Judy R. Berlfein and Antonio J. Grillo-Lopez

Non-Hodgkins Lymphoma: Review of Conventional Treatments

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 279-291
Authors: P. Multani, C.A. White and A. Grillo-Lopez

Highly Active Antiretroviral Therapy is Associated with Improved Survival among Patients with AIDS-Related Primary Central Nervous System Non-Hodgkins Lymphoma

Journal: Current HIV Research
Volume: 4,Issue: 3
Page: 375-378
Authors: Catherine Diamond, Thomas H. Taylor, Theresa Im, Mohammed Miradi, Mark Wallace and Hoda Anton-Culver

Radioimmunotherapy of Non-Hodgkins Lymphomas

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1293-1300
Authors: Bruce D. Cheson

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 4,Issue: 4
Page: 221-238
Authors: Christine A. White

Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma

Journal: Current HIV Research
Volume: 2,Issue: 3
Page: 215-221
Authors: Deirdre Killebrew and Bruce Shiramizu

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges

Journal: Current Drug Targets
Volume: 18,Issue: 7
Page: 766-771
Authors: Sabino Russi, Loredana Sansonno and Domenico Sansonno*

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 301-311
Authors: A. J. Grillo-Lopez, B.K. Dallaire, A. McClure, R. Weaver, C. Varns, A. Wei, R. Allen, D. Lee, D. Shen, J. Leonard, P.Multani and C.A.White

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 2
Page: 160-168
Authors: Parul Thakral, Suhas Singla, Atul Vashist, Madhav P. Yadav, Santosh K. Gupta, Jaya S. Tyagi, Atul Sharma, Chandra S. Bal, Snehlata and Arun Malhotra

The Role of Major Histocompatibility Complex Polymorphisms in the Incidence and Outcome of Non-Hodgkin Lymphoma

Journal: Current Immunology Reviews
Volume: 5,Issue: 4
Page: 300-310
Authors: Jacek Nowak, Przemyslaw Juszczynski and Krzysztof Warzocha

Genetic Idiotypic and Tumor Cell-Based Vaccine Strategies for Indolent Non Hodgkins Lymphoma

Journal: Current Gene Therapy
Volume: 5,Issue: 5
Page: 511-521
Authors: Pier A. Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, Salvatore Siena and Alessandro M. Gianni

Antiangiogenic Therapies in Non-Hodgkin's Lymphoma

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1030-1043
Authors: J. Ruan

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 1
Page: 20-27
Authors: Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle

TP73, An Under-Appreciated Player in Non-Hodgkin Lymphoma Pathogenesis and Management

Journal: Current Molecular Medicine
Volume: 14,Issue: 4
Page: 432-439
Authors: H.M. Hassan, B.J. Dave and R.K. Singh

Angiogenesis and AngiomiRs in Non-Hodgkin´s Lymphomas

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 1
Page: 20-25
Authors: Natalia Morais Borges and Gisele W.B. Colleoni

Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma

Journal: Clinical Cancer Drugs
Volume: 2,Issue: 1
Page: 44-53
Authors: Karen E. Thudium, Lance Wollenberg, Cory Mavis, Jenny Gu, Gerald J. Fetterly, Myron S. Czuczman and Francisco J. Hernandez-Ilizaliturri

Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 341-349
Authors: C. Krasner and R.M. Joyce

Development and biological studies of 177Lu-DOTA-rituximab for the treatment of Non-Hodgkin’s lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 1
Page: 54-63
Authors: Adriana V.F. Massicano, Priscilla B. Pujatti, Lais F. Alcarde, Miriam F. Suzuki, Patrick J. Spencer and Elaine B. Araújo

Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 41-51
Authors: Erin Reid, Ajay Nooka, Jawaunna Blackmon and Mary Jo Lechowicz

Angiogenesis in Lymphoma: A Short Review

Journal: Current Molecular Medicine
Volume: 5,Issue: 7
Page: 609-613
Authors: Anas Younes

Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 790-800
Authors: Aude-Helene Capietto, Samarh Keirallah, Emilie Gross, Nicolas Dauguet, Emilie Laprevotte, Christine Jean, Julie Gertner-Dardenne, Christine Bezombes, Anne Quillet-Mary, Mary Poupot, Loic Ysebaert, Guy Laurent and Jean-Jacques Fournie

Proteomic Analysis of Mitochondria in Raji Cells Following Exposure to Radiation: Implications for Radiotherapy Response

Journal: Protein & Peptide Letters
Volume: 16,Issue: 11
Page: 1350-1359
Authors: Yujie Jiang, Xin Liu, Xiaosheng Fang and Xin Wang

Composite Lymphomas: A Challenging Entity

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 2
Page: 80-89
Authors: Sotirios Sachanas, Gerassimos A. Pangalis, Christina Kalpadakis, Xanthi Yiakoumis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Flora Kontopidou, Styliani Kokoris, Marina Siakantaris, Nora-Athina Viniou, Pinelopi Korkolopoulou, Helen Papadaki, Panayiotis Panayiotidis and Maria Angelopoulou

Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1329-1334
Authors: Cornelius Miething, Christian Peschel and Justus Duyster

Diffuse Large B-Cell Lymphoma Presenting as an Anterior Chest Wall Mass: A Case Report and Literature Review

Journal: Current Respiratory Medicine Reviews
Volume: 5,Issue: 4
Page: 239-241
Authors: Chrissy A. Navejar and Michael J. Morris

Radionuclide Therapy of Cancer with Radiolabeled Antibodies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 335-343
Authors: Wim J. Oyen, E. J. Postema, Frans H. Corstens, Otto C. Boerman and Manuel J. Koppe

Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 2
Page: 74-81
Authors: Luca Arcaini and Raffaele Bruno

Radioimmunotherapy of Solid Tumors: Searching for the Right Target

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 26-44
Authors: Hong Song and George Sgouros

Novel and Emerging Drugs for Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 5
Page: 522-530
Authors: E. M. Stein and M. S. Tallman

Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 65-69
Authors: Kathy J. Helzlsouer and Lisa Gallicchio

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 11-25
Authors: Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 15-34
Authors: Tadeusz Robak, Agnieszka Wierzbowska and Ewa Robak

Radioimmunotherapy of B-Cell NHL

Journal: Current Pharmaceutical Biotechnology
Volume: 2,Issue: 4
Page: 327-339
Authors: R.F. Meredith and S.J. Knox

NBS1 Heterozygosity and Cancer Risk

Journal: Current Genomics
Volume: 9,Issue: 4
Page: 275-281
Authors: Alessandra di Masi and Antonio Antoccia

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 21
Page: 2051-2060
Authors: M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps

Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 9
Page: 966-982
Authors: J. Harvey Turner

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman

Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?

Journal: Current Drug Targets
Volume: 11,Issue: 2
Page: 179-186
Authors: P. L. Lakatos and P. Miheller

Bortezomib in the Treatment of Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 3
Page: 397-403
Authors: Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti

Use of Radioimmunotherapy in Stem Cell Transplantation and Posttransplantation: Focus on Yttrium 90 Ibritumomab Tiuxetan

Journal: Current Stem Cell Research & Therapy
Volume: 2,Issue: 3
Page: 239-248
Authors: Arturo Molina, Amrita Krishnan, Henry Fung, Ian W. Flinn, David Inwards, Jane N. Winter and Auayporn Nademanee

Gallium in Cancer Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 15
Page: 1575-1583
Authors: Michael A. Jakupec and Bernhard K. Keppler

Malignancy Risk in Systemic Lupus: Recent Research and Ongoing Challenges

Journal: Current Rheumatology Reviews
Volume: 4,Issue: 1
Page: 59-62
Authors: Sasha Bernatsky, Rosalind Ramsey-Goldman and Ann E. Clarke

Chemistry and Pharmacology of Imexon and Related Cyanoaziridines

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 33
Page: 5745-5753
Authors: W.A. Remers and R.T. Dorr

Antagonists of Growth Hormone-Releasing Hormone in Oncology

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 9,Issue: 3
Page: 163-170
Authors: Andrew V. Schally and Jozsef L. Varga

Immunotoxins in the Treatment of Hematologic Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1301-1311
Authors: Robert J. Kreitman and Ira Pastan

Interferon: Cellular Executioner or White Knight?

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 12
Page: 1279-1289
Authors: S. G. Maher, A. L. Romero-Weaver, A. J. Scarzello and A. M. Gamero

Relation Between Helicobacter Pylori Infection and Gastroduodenal Diseases

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 109-115
Authors: Antonio De Luca, Elisabetta Buommino, Lucrezia Manente and Maria A. Tufano

Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 6
Page: 421-444
Authors: T. Robak, A. Korycka, M. Kasznicki, A. Wrzesien-Kus and P. Smolewski

Molecular Analysis of Primary Central Nervous System and Primary Intraocular Lymphomas.

Journal: Current Molecular Medicine
Volume: 1,Issue: 2
Page: 259-272
Authors: N. Tuaillon and C. C. Chan

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 1
Page: 1-9
Authors: A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg

Bcl-2 Antisense in the Treatment of Human Malignancies: A Delusion in Targeted Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 8,Issue: 6
Page: 373-381
Authors: Bjorn Tore Gjertsen, Therese Bredholt, Nina Anensen and Olav Karsten Vintermyr

Polymorphisms of Human N-Acetyltransferases and Cancer Risk

Journal: Current Drug Metabolism
Volume: 9,Issue: 6
Page: 520-531
Authors: Jose A.G Agundez

Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 9
Page: 976-983
Authors: Anna Korycka, Jerzy Z. Blonski and Tadeusz Robak

Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 9
Page: 805-824
Authors: Erik De Clercq

dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention

Journal: Current Protein & Peptide Science
Volume: 2,Issue: 4
Page: 349-360
Authors: Friedrich A. Grasser, Bernd F.M. Romeike, Gerald Niedobitek, John Nicholls and Elisabeth Kremmer

Is there a Benefit from the Concomitant Use of Immunosupression with Anti-TNF in Crohns Disease; Heads or Tails?

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 3
Page: 152-158
Authors: Peter Laszlo Lakatos

B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11,Issue: 2
Page: 99-111
Authors: Mario Salvi, Guia Vannucchi and Paolo Beck-Peccoz

Viral and Cellular Cytokines as Therapeutic Targets in AIDS-Related Lymphoproliferative Disorders

Journal: Current Drug Target -Cardiovascular & Hematological Disorders
Volume: 3,Issue: 1
Page: 81-96
Authors: Yoshiyasu Aoki and Giovanna Tosato

Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice

Journal: Current HIV Research
Volume: 8,Issue: 6
Page: 482-486
Authors: Miguel Genebat, Ezequiel Ruiz-Mateos, Ildefonso Pulido, Alejandro Gonzalez-Serna, Antonio Garcia-Perganeda, Gema Mendez, Maria Concepcion Romero-Sanchez, Sara Ferrando-Martinez and Manuel Leal

The Impact of HAART on HPV-Related Cervical Disease

Journal: Current HIV Research
Volume: 8,Issue: 7
Page: 493-497
Authors: David H. Adler

Heat Shock Proteins (HSPs) Based Anti-Cancer Vaccines

Journal: Current Molecular Medicine
Volume: 12,Issue: 9
Page: 1183-1197
Authors: D.R. Ciocca, N. Cayado-Gutierrez, M. Maccioni and F.D. Cuello-Carrion

Pioglitazone and Cancer: Angel or Demon?

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 27
Page: 4913-4929
Authors: Michael S. Kostapanos, Moses S. Elisaf and Dimitri P. Mikhailidis

Antiangiogenic Therapy in Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 11
Page: 1221-1234
Authors: Moehler T. M., Hillengass J., Goldschmidt H. and Ho A. D.

Yttrium-90 – Current Status, Expected Availability and Applications of a High Beta Energy Emitter

Journal: Current Radiopharmaceuticals
Volume: 5,Issue: 3
Page: 253-263
Authors: R. Leyva Montana, I. Hernandez Gonzalez, A. Alberti Ramirez, L. Garaboldi and M. Chinol

Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 26
Page: 3165-3189
Authors: Tadeusz Robak, Ewa Lech-Maranda, Anna Korycka and Ewa Robak

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 2
Page: 156-171
Authors: Tadeusz Robak

Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression

Journal: Current Enzyme Inhibition
Volume: 8,Issue: 2
Page: 107-117
Authors: Emine Ercikan Abali, Hilal Celikkaya, Yi-Ching Hsieh, Debabrata Banerjee and Joseph R. Bertino

Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 27
Page: 4187-4196
Authors: Lin Wu, Sanbao Su, Fengming Liu, Tao Xu, Xiaoxiao Wang, Yan Huang, Xinlu Sun, Xiaowen Ge, Ting Chen, Huixia Liu, Chun Wang, Michael Chorev, Ting Xu and Xuebin Qin

Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 140-146
Authors: William B. Grant

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Journal: Current Drug Therapy
Volume: 7,Issue: 4
Page: 281-289
Authors: Ravindra R. Chuda, Prakash Vishnu and David Aboulafia

Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 8
Page: 1005-1016
Authors: Francesca Merchionne, Pasquale Iacopino, Carla Minoia, Angela Iacobazzi, Antonio Rana, Simona Serrati, Giacoma De Tullio, Giacomo Loseto, Angela Lapietra, Annunziata Lucarelli and Attilio Guarini

Targeted Radionuclide Therapy - An Overview

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 3
Page: 152-180
Authors: Ashutosh Dash, F. F. (Russ) Knapp and M. R.A. Pillai

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 5
Page: 423-444
Authors: Dariush Shanehbandi, Jafar Majidi*, Tohid Kazemi*, Behzad Baradaran and Leili Aghebati-Maleki

Standardization of Procedures for the Preparation of 177Lu- and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation

Journal: Current Radiopharmaceuticals
Volume: 8,Issue: 1
Page: 62-68
Authors: Wioletta Wojdowska, Urszula Karczmarczyk, Michal Maurin, Piotr Garnuszek and Renata Mikolajczak

High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders

Journal: Current HIV Research
Volume: 15,Issue: 4
Page: 258-265
Authors: Andrea Calcagno *, Anna Lucchini , Daniele Caracciolo, Rosanna Balbiano, Margherita Bracchi , Francesca Sordella, Giovanna Gregori , Filippo Lipani , Sabrina Audagnotto, Monica Chiriotto , Giovanni Cavaglià , Valeria Ghisetti, Giovanni Di Perri and Stefano Bonora

Editorial Review of 2014

Journal: Current Radiopharmaceuticals
Volume: 7,Issue: 1
Page: 1-4
Authors: Sean L. Kitson and Luigi Mansi

Results 1 - 76 of 76